These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

200 related items for PubMed ID: 33543658

  • 1. Ki-67 Labeling Index Variability Between Surgically Resected Primary and Metastatic Hepatic Lesions of Gastroenteropancreatic Neuroendocrine Neoplasms.
    Furukawa T, Ozaka M, Takamatsu M, Takazawa Y, Inamura K, Inoue Y, Mie T, Takeda T, Kanata R, Kasuga A, Matsuyama M, Sasaki T, Takahashi Y, Sasahira N.
    Int J Surg Pathol; 2021 Aug; 29(5):475-481. PubMed ID: 33543658
    [Abstract] [Full Text] [Related]

  • 2. Variability of the Ki-67 proliferation index in gastroenteropancreatic neuroendocrine neoplasms - a single-center retrospective study.
    Shi H, Zhang Q, Han C, Zhen D, Lin R.
    BMC Endocr Disord; 2018 Jul 28; 18(1):51. PubMed ID: 30055596
    [Abstract] [Full Text] [Related]

  • 3. Clinical analysis of gastroenteropancreatic neuroendocrine tumor with liver metastasis, compared with primary hepatic neuroendocrine tumor.
    Shen YH, Chen S, Zhang WT, Ji Y, Yu L, Sun HC, Qiu SJ, Ren N, Zhou J.
    J Cancer Res Ther; 2014 Dec 28; 10 Suppl():276-80. PubMed ID: 25693935
    [Abstract] [Full Text] [Related]

  • 4. Grade Increases in Gastroenteropancreatic Neuroendocrine Tumor Metastases Compared to the Primary Tumor.
    Grillo F, Albertelli M, Brisigotti MP, Borra T, Boschetti M, Fiocca R, Ferone D, Mastracci L.
    Neuroendocrinology; 2016 Dec 28; 103(5):452-9. PubMed ID: 26337010
    [Abstract] [Full Text] [Related]

  • 5. Liver Transplant for Metastatic Neuroendocrine Tumors: A Single-Center Experience in Hungary.
    Korda D, Doros A, Piros L, Gerlei Z, Haboub-Sandil A, Mándli T, Fazakas J, Deák ÁP, Máthé Z.
    Transplant Proc; 2019 May 28; 51(4):1251-1253. PubMed ID: 31101208
    [Abstract] [Full Text] [Related]

  • 6. Palliative resection of primary site in advanced gastroenteropancreatic neuroendocrine tumors improves survivals.
    Kıvrak Salim D, Bayram S, Gömceli İ, Çekin AH, Karaca M, Koçer M, Yıldız M.
    Turk J Gastroenterol; 2019 Oct 28; 30(10):910-916. PubMed ID: 31625933
    [Abstract] [Full Text] [Related]

  • 7. HSP90 expression and early recurrence in gastroenteropancreatic neuroendocrine tumors: Potential for a novel therapeutic target.
    Gamboa AC, Ethun CG, Postlewait LM, Lopez-Aguiar AG, Zhelnin K, Krasinskas A, El-Rayes BF, Russell MC, Kooby DA, Staley CA, Cardona K, Maithel SK.
    Surg Oncol; 2020 Dec 28; 35():460-465. PubMed ID: 33080545
    [Abstract] [Full Text] [Related]

  • 8. Surgery Provides Long-Term Survival in Patients with Metastatic Neuroendocrine Tumors Undergoing Resection for Non-Hormonal Symptoms.
    Chakedis J, Beal EW, Lopez-Aguiar AG, Poultsides G, Makris E, Rocha FG, Kanji Z, Weber S, Fisher A, Fields R, Krasnick BA, Idrees K, Marincola-Smith P, Cho C, Beems M, Pawlik TM, Maithel SK, Schmidt CR, Dillhoff M.
    J Gastrointest Surg; 2019 Jan 28; 23(1):122-134. PubMed ID: 30334178
    [Abstract] [Full Text] [Related]

  • 9. Gastroenteropancreatic High-Grade Neuroendocrine Neoplasms: Histology and Molecular Analysis, Two Sides of the Same Coin.
    Busico A, Maisonneuve P, Prinzi N, Pusceddu S, Centonze G, Garzone G, Pellegrinelli A, Giacomelli L, Mangogna A, Paolino C, Belfiore A, Kankava K, Perrone F, Tamborini E, Pruneri G, Fazio N, Milione M.
    Neuroendocrinology; 2020 Jan 28; 110(7-8):616-629. PubMed ID: 31557757
    [Abstract] [Full Text] [Related]

  • 10. Clinicopathological heterogeneity between primary and metastatic sites of gastroenteropancreatic neuroendocrine neoplasm.
    Shi H, Jiang C, Zhang Q, Qi C, Yao H, Lin R.
    Diagn Pathol; 2020 Sep 11; 15(1):108. PubMed ID: 32917216
    [Abstract] [Full Text] [Related]

  • 11. Comparative Clinical Analysis of Gastroenteropancreatic Neuroendocrine Carcinomas with Liver Metastasis and Primary Hepatic Neuroendocrine Carcinomas.
    Qiu MJ, Chen YB, Bi NR, Yang SL, He XX, Xiong ZF.
    Dis Markers; 2018 Sep 11; 2018():9191639. PubMed ID: 30416612
    [Abstract] [Full Text] [Related]

  • 12. Resection of primary tumor may prolong survival in metastatic gastroenteropancreatic neuroendocrine tumors.
    Tierney JF, Chivukula SV, Wang X, Pappas SG, Schadde E, Hertl M, Poirier J, Keutgen XM.
    Surgery; 2019 Mar 11; 165(3):644-651. PubMed ID: 30366604
    [Abstract] [Full Text] [Related]

  • 13. Role of Ki-67 proliferation index in the assessment of patients with neuroendocrine neoplasias regarding the stage of disease.
    Miller HC, Drymousis P, Flora R, Goldin R, Spalding D, Frilling A.
    World J Surg; 2014 Jun 11; 38(6):1353-61. PubMed ID: 24493070
    [Abstract] [Full Text] [Related]

  • 14. Effect of tumor heterogeneity on the assessment of Ki67 labeling index in well-differentiated neuroendocrine tumors metastatic to the liver: implications for prognostic stratification.
    Yang Z, Tang LH, Klimstra DS.
    Am J Surg Pathol; 2011 Jun 11; 35(6):853-60. PubMed ID: 21566513
    [Abstract] [Full Text] [Related]

  • 15. Pediatric gastroenteropancreatic neuroendocrine tumor: A case report and review of the literature.
    Gaiani F, de'Angelis N, Minelli R, Kayali S, Carra MC, de'Angelis GL.
    Medicine (Baltimore); 2019 Sep 11; 98(37):e17154. PubMed ID: 31517859
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Comparison of Monitor-Image and Printout-Image Methods in Ki-67 Scoring of Gastroenteropancreatic Neuroendocrine Tumors.
    Dogukan FM, Yilmaz Ozguven B, Dogukan R, Kabukcuoglu F.
    Endocr Pathol; 2019 Mar 11; 30(1):17-23. PubMed ID: 30367334
    [Abstract] [Full Text] [Related]

  • 18. Hormonal tumor mapping for liver metastases of gastroenteropancreatic neuroendocrine neoplasms: a novel therapeutic strategy.
    Maekawa A, Kudo A, Kishino M, Murase Y, Watanabe S, Ishikawa Y, Ueda H, Akahoshi K, Ogawa K, Ono H, Tanaka S, Kinowaki Y, Tanabe M.
    J Cancer Res Clin Oncol; 2022 Mar 11; 148(3):697-706. PubMed ID: 33904982
    [Abstract] [Full Text] [Related]

  • 19. Results after surgical treatment of liver metastases in patients with high-grade gastroenteropancreatic neuroendocrine carcinomas.
    Galleberg RB, Knigge U, Tiensuu Janson E, Vestermark LW, Haugvik SP, Ladekarl M, Langer SW, Grønbæk H, Österlund P, Hjortland GO, Assmus J, Tang L, Perren A, Sorbye H.
    Eur J Surg Oncol; 2017 Sep 11; 43(9):1682-1689. PubMed ID: 28522174
    [Abstract] [Full Text] [Related]

  • 20. Diagnostic and therapeutic role of endoscopy in gastroenteropancreatic neuroendocrine neoplasms.
    Attili F, Capurso G, Vanella G, Fuccio L, Delle Fave G, Costamagna G, Larghi A.
    Dig Liver Dis; 2014 Jan 11; 46(1):9-17. PubMed ID: 23731843
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.